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2Abstract
Background: Previous research suggests that patients are dissatisfied with information
provided about medication prescribed for mental illness, but has not identified which
aspects of information provision are unsatisfactory.
Methods: 223 members of the Manic Depression Fellowship (MDF) completed the
Satisfaction with Information about Medicines Scale (SIMS), a validated measure of
patients’ satisfaction with various aspects of information provision.
Results: Patients reported highest dissatisfaction with information about potential problems
associated with medication; over 60% of participants reported dissatisfaction with
information about the risks of side effects and whether the medication would affect their
sex lives. Participants were significantly less satisfied with information about potential
problems associated with their medication than people prescribed medication for HIV, in a
previously reported study (p<.01). Those reporting low adherence to medication had
significantly lower satisfaction with information scores than those reporting high adherence
(p<.05).
Limitations: The sample could be prone to selection bias; participants were members of an
organisation for people affected by bipolar disorder, whilst the comparator group was a
NHS HIV clinic sample. Furthermore, the objective amount and type of information
provided was not assessed, therefore the cause of patients’ dissatisfaction is not known.
3Conclusions: Perceived satisfaction with information is low, particularly in relation to
possible drug side-effects. Health practitioners need to elicit individuals’ information
requirements and tailor information to meet their needs, in order to facilitate informed
choice and adherence to treatment. Moreover, they need to provide information in a
manner appropriate for a patient’s cognitive functioning at different illness phases.
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4Introduction
In order to make informed decisions about medication patients require adequate
information. Research suggests, however, that patients may be dissatisfied with
information received about medication prescribed for mental illness. For example, in a
survey of over 2500 members of the Manic Depression Fellowship, National Schizophrenia
Fellowship and MIND, 27% of participants reported that their doctors had not talked to
them about their medication. Comparable results emerge from inpatient studies, with one
reporting that just 61% of patients agreed with the statement “Doctors have explained my
treatment clearly to me” (Barker et al., 1996).
Information provision is not exclusively the responsibility of doctors; patients in the UK are
cared for by multidisciplinary mental health teams and it is likely that information will come
from a variety of sources, including doctors, psychiatric nurses, pharmacists, social
workers and support workers. Indeed, following the introduction of non-medical
prescribing, patients are increasingly prescribed medication by Nurse and Pharmacist
Independent Prescribers. However, studies which have not focussed specifically on
satisfaction with information provided by doctors have found similar results. For example,
in a questionnaire study completed by 69 patients receiving secondary care for a diagnosis
of schizophrenia, 46% reported that they had not been warned about potential side effects
of medication (Gray et al., 2005). Similarly, in an interview-based study involving 84
outpatients with a diagnosis of schizophrenia, 56% reported not having received enough
information about their medication (Paton and Esop, 2005).
5Whilst there is clearly a need to address information provision for patients with mental
illness, it is not yet known which specific aspects of information about medication patients
find inadequate. The present study used a validated questionnaire (Horne et al., 2001) to
profile patients’ satisfaction with information about medication prescribed for bipolar
disorder.
6Methods
259 Manic Depression Fellowship (MDF) members responded to a flyer in Pendulum, the
organisation’s quarterly journal. They were sent a questionnaire booklet with a stamped
addressed envelope for its return.
The booklet included the Satisfaction with Information about Medicines Scale (SIMS;
Horne et al., 2001), which assesses the extent to which participants are satisfied with 17
aspects of information considered essential for the optimum use of medicines (Association
of the British Pharmaceutical Industry, 1988). The questionnaire does not focus on
specific information providers (e.g. doctors, nurses, pharmacists) nor on specific formats of
information (e.g. written, verbal), rather it assess patients’ overall satisfaction with the
information received about their medication. Nine items refer to information received about
the Action and Usage of the medication (e.g. what it is for, how long it takes to work; SIMS-
AU subscale) and eight items refer to information received about the Potential Problems of
the medication (e.g. whether it will have side effects, whether it will interfere with other
medication; SIMS-PP subscale). For each item, participants are asked to rate the amount
of information they have received, indicating “too much”, “about right”, “too little”, “none
received” or “none needed”. Participants reporting that the information was “about right” or
indicating “none needed” are classified as satisfied (scored 1). Those reporting that the
information was “too much”, “too little” or indicating “none received” are classified as
dissatisfied (scored 0). A satisfaction rating for each subscale is obtained by summing the
scores for each item in the subscale. Scores can range from 0 to 9 for the Action and
Usage subscale and from 0 to 8 for the Potential Problems subscale (high scores indicate
7high satisfaction). Scores for the Action and Usage subscale and the Potential Problems
subscale are summed to give an overall satisfaction with information about medicines
score.
The questionnaire booklet also included the Medication Adherence Report Scale (MARS;
Horne et al., 2001), a five-item scale that asks patients to estimate on a five-point scale
(always to never), how often they engage in five types of nonadherent behaviour with their
medicines (e.g. forget to take them, take less than instructed, stop taking them, miss out a
dose, alter the dose). Scores are summed to give an overall adherence score ranging
from 5 to 25, with high scores indicating high adherence. Participants were grouped
according to their MARS score, with the third scoring the lowest (<21) classified as low
adherers and the two thirds scoring the highest classified as high adherers. (Approximately
a third of patients are thought to be low adherers to medication prescribed for bipolar
disorder; Scott & Pope, 2002)
An independent samples t-test was used to compare high and low adherers on their
overall satisfaction with information about medication score. In addition, independent
samples t-tests were used to compare mean satisfaction with information about medicines
in the current sample with that reported in a previously published study, involving 115
people who were diagnosed HIV positive and had been offered antiretroviral therapy by an
outpatient NHS clinic in Brighton, UK (full methodology reported in Gellaitry et al., 2005).
These data were also collected via a postal questionnaire. A sample size calculation
conducted using G-Power software (Erdfelder et al., 1996) revealed that this sample size
would be sufficient to detect a medium effect size, with 80% power and an alpha of .05.
8Results
223 (86%) participants returned completed questionnaires. The mean age of participants
was 48 years (range 22-77). 140 (64%) were female and 97 (44%) were married/ with a
partner. The mean age of diagnosis was 34 years (range 12-68), with a mean number of
hospital admissions relating to bipolar disorder of 4 (range 0-15).
Figure 1 provides a profile of patient satisfaction with the 17 medicines information topics.
Over 50% of participants were dissatisfied with the information they had received about
how the medication worked, how they could tell if it was working, how long they needed to
be on it, whether it had unwanted side effects, what to do if side effects were experienced
and whether it could interfere with other medications. Over 60% of participants were
dissatisfied with the information they had received about the risks of getting side effects
and whether the medication would affect their sex lives. In all cases, dissatisfaction
resulted from patients reporting having received too little or no information, rather than too
much.
Figure 1 shows differences in satisfaction between this sample prescribed medication for
bipolar disorder and a previous sample prescribed medication for HIV. Independent
samples t-tests revealed that those prescribed medication for bipolar disorder were
significantly less satisfied than those prescribed medication for HIV with information about
the Potential Problems of the medication (t (326) = -4.4, p<.01), but there was no
significant difference between the groups in terms of satisfaction with information about the
Action and Usage of the medication (t(320) = -.54, p>.05).
9An independent samples t-test revealed that those reporting low adherence to medication
prescribed for bipolar disorder (scoring less than 21 on the MARS) were significantly less
satisfied with information received about medication than those reporting high adherence
(t(192) = 1.66, p<.05 (1 tailed)).
Discussion
This survey of members of the MDF found a high prevalence of perceived dissatisfaction
with information about medication across a range of informational topics considered
essential for informed choice and safe usage. Moreover, levels of satisfaction were
significantly lower in comparison with a previous study of patients diagnosed with HIV
(Gellaitry et al., 2004). In particular, patients reported dissatisfaction with information
provided about medication side effects, recently rated the most important aspect of
information about medication by patients attending outpatient psychiatry appointments
(Perreault et al., 2006).
Limitations
It should be noted that the sample could be prone to selection bias: participants were
members of the Manic Depression Fellowship, a user-led organisation providing
information and support for those affected by bipolar disorder. However, one would expect
that members of the MDF would generally be better informed about medication than a
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random NHS sample, and if anything, the results might provide an overly optimistic view of
levels of satisfaction with information.
The opportunistic comparison with the HIV sample should be treated with caution as the
methodology was not identical in the two groups. Indeed, those in the HIV sample were
recruited to the study following an offer of antiretroviral treatment. They may therefore
have received information more recently than those in the bipolar sample, potentially
influencing their reported satisfaction with information. Ideally the same sampling methods
would have been used to enable direct comparisons across illness groups. However,
differences in satisfaction between the bipolar and HIV samples were large and may not
be an artefact of the study design.
Whilst this study has highlighted low satisfaction with information about medicines
amongst patients with bipolar disorder, the reasons for this are not yet known. One
explanation could be that patients have not been provided with sufficient information about
their medication. Our intention was not to assess the objective amount of information
actually provided, rather we wanted to examine patients’ perceptions of whether they had
received enough information. Previous research, however, suggests that simply providing
access to information does not necessarily increase patients’ satisfaction with information,
as patients do not always attend to the information provided. Indeed, two studies in mental
health settings have reported that approximately 50% of patients do not think they have
been given written information about medication, even though drug information sheets are
now routinely provided (Gray et al., 2005; National Schizophrenia Fellowship, 2000).
Similarly, Paton & Esop (2005) reported that providing a touch screen computer in the
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outpatient waiting room, giving access to easily accessible information about medication,
did not make patients diagnosed with schizophrenia any more satisfied that they had
received enough information about medication than those without a touch screen computer
in the waiting room.
This blanket approach to information provision may not be successful as information needs
differ between individuals; people prescribed the same medicines require different levels of
information because they deal with being ill in different ways. Some react by becoming
actively involved with their treatment and seek detailed information. In contrast, others
respond with more avoidant coping strategies (e.g. by wanting others to “take charge”, and
may find additional information unhelpful or even distressing (Weinman, 1990). An
important arbiter of the quality of medication information is therefore the extent to which
individuals perceive that it has met their specific needs and are satisfied with the
information provided (Horne et al., 2001). Further research is required to understand why
current information provision does not appear to be meeting the needs of so many of the
participants. One possibility is that the information is not sufficiently targeted to meet
patients’ individual needs. information provision may be more effective if individuals’
specific beliefs and concerns are elicited and addressed (Horne, 2003). Another
consideration is that bipolar disorder is associated with attention and memory deficits that




The findings have implications for informed choice about medicines, as this study suggests
that many participants do not feel they have been provided with satisfactory information,
particularly in relation to possible drug side-effects. Attention needs to be given to the
format and timing of information provision. Providing information about medicines
prescribed for bipolar disorder may be particularly problematic if treatment initiation is
involuntary and/or at a time when patients are too unwell to process information. It is likely
that one-off information provision at the time of prescribing is not sufficient and that a more
long term approach needs to be adopted, encompassing periods of time when the patient
is not acutely unwell. Indeed recent NICE guidelines emphasis this, stating that health
professionals should provide relevant information (including information about medication)
at every stage of assessment, diagnosis and treatment (National Institute for Clinical
Excellence, 2006).
The findings also have implications for nonadherence to medication. This study suggests
that perceived satisfaction with information received about medication is associated with
low adherence. Previous research has found a similar association between satisfaction
with information and adherence to medication in chronic illness (Kendrew et al., 2001).
Improving patient satisfaction with information about medication may therefore improve
levels of adherence to medication. Reviews of adherence interventions in bipolar disorderr
also emphasise the need for moderate to long term intervention strategies, given the
chronic nature of the condition (Sajatovic et al., 2004).
This study has demonstrated the utility of the SIMS for identifying patient satisfaction with
information about medicines and identifying areas of unmet need. It could be used as an
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audit tool at individual and group levels. It has also illustrated a need for health
practitioners to elicit individuals’ information requirements and to tailor information to meet
their needs, in order to facilitate informed choice and adherence to treatment.
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